Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons
Abstract
neuronal sensitivity to neuromodulators and therapeutic drugs. Mu and Delta opioid receptors (MORs and DORs) can interact when overexpressed in the same cells, but whether co-expression of endogenous MORs and DORs in neurons leads to functional interactions is unclear. Here, in mice, we show that both MORs and DORs inhibit parvalbumin-expressing basket cells (PV-BCs) in hippocampal CA1 through partially occlusive signaling pathways that terminate on somato-dendritic potassium channels and presynaptic calcium channels. Using photoactivatable opioid neuropeptides, we find that DORs dominate the response to enkephalin in terms of both ligand-sensitivity and kinetics, which may be due to relatively low expression levels of MOR. Opioid-activated potassium channels do not show heterologous desensitization, indicating that MORs and DORs signal independently. In a direct test for heteromeric functional interactions, the DOR antagonist TIPP-Psi does not alter the kinetics or potency of either the potassium channel or synaptic responses to photorelease of the MOR agonist DAMGO. Thus, aside from largely redundant and convergent signaling, MORs and DORs do not functionally interact in PV-BCs in a way that impacts somato-dendritic potassium currents or synaptic transmission. These findings imply that crosstalk between MORs and DORs, either in the form of physical interactions or synergistic intracellular signaling, is not a preordained outcome of co-expression in neurons.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for all figures.
Article and author information
Author details
Funding
National Institute on Drug Abuse (R00DA034648)
- Matthew Ryan Banghart
National Institute of General Medical Sciences (R35GM133802)
- Matthew Ryan Banghart
National Institute of Neurological Disorders and Stroke (U01NS113295)
- Matthew Ryan Banghart
National Institute of Mental Health (U01NS113295)
- Matthew Ryan Banghart
Brain and Behavior Research Foundation (NARSAD Young Investigators Award)
- Matthew Ryan Banghart
Esther A. and Joseph Klingenstein Fund (Klingenstein-Simons Fellowship in Neuroscience)
- Matthew Ryan Banghart
National Institute of General Medical Sciences (T32GM007240)
- Xinyi Jenny He
National Institute of Neurological Disorders and Stroke (R01NS111162)
- Brenda L Bloodgood
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: All procedures were performed in accordance with protocols approved by the University of California San Diego Institutional Animal Care and Use Committee (IACUC) following guidelines described in the the US National Institutes of Health Guide for Care and Use of Laboratory Animals (UCSD IACUC protocol S16171). All surgery was performed under isoflurane anesthesia.
Copyright
© 2021, He et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,685
- views
-
- 353
- downloads
-
- 27
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.